![Gavin Malenfant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gavin Malenfant
No open positions remaining
Profile
Gavin T.
Malenfant is the founder of GMalenfant Consulting LLC, founded in 2018.
Former positions include Head-Operations & Vice President at Sarepta Therapeutics, Inc. from 2015 to 2016, Head-Operations at Genzyme Corp., Head-Corporate Operations & Program Management at Akebia Therapeutics, Inc. from 2016 to 2018, and Chief Operating Officer at ProMIS Neurosciences, Inc. from 2021 to 2025.
Education includes an undergraduate degree from the University of Massachusetts Boston.
Former positions of Gavin Malenfant
| Companies | Position | End |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Chief Operating Officer | 14/02/2025 |
GMalenfant Consulting LLC | Founder | 01/10/2021 |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2018 |
| SAREPTA THERAPEUTICS, INC. | Chief Operating Officer | 01/01/2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Chief Operating Officer | - |
Training of Gavin Malenfant
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
University of Massachusetts Boston
 University of Massachusetts Boston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GMalenfant Consulting LLC |
- Stock Market
- Insiders
- Gavin Malenfant
